Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 13, 2025 08:00 ET | Source: Myriad Genetics, Inc.

New Myriad Genetics Survey Uncovers Women Fear Screenings—But Feel Reassured by the Results

SALT LAKE CITY, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today released findings from its latest...
February 27, 2025 16:15 ET | Source: Myriad Genetics, Inc.

Myriad Genetics and Gabbi to Work Together to Increase Access to Hereditary Cancer Risk Assessment Tools

Myriad Genetics announced a collaboration with Gabbi to provide an integrated offering for breast cancer risk assessment.
February 06, 2025 08:30 ET | Source: Myriad Genetics, Inc.

Myriad Genetics and CancerCARE for Life Announce Agreement to Advance Access to MyRisk with RiskScore Hereditary Cancer Test

Myriad Genetics and CancerCARE for Life announced an agreement designed to enhance education and access to hereditary cancer testing.
January 21, 2025 08:30 ET | Source: Myriad Genetics, Inc.

Myriad Genetics Announces Hereditary Cancer Risk Assessment Program Study Published in Obstetrics & Gynecology

Myriad Genetics announced a hereditary cancer risk assessment program study was published in Obstetrics & Gynecology (also known as The Green Journal).
January 09, 2025 16:30 ET | Source: Myriad Genetics, Inc.

Myriad Genetics Signs Agreement with Nationally Renowned Sports Broadcaster Hannah Storm to Promote the Importance of Knowing Family Cancer History

Myriad Genetics announced it signed an agreement with sports broadcaster Hannah Storm to promote the importance of knowing family cancer history.
December 19, 2024 16:15 ET | Source: Myriad Genetics, Inc.

Myriad Genetics’ RiskScore Study Named One of the Top 10 Significant Advances in Genomic Medicine in American Journal of Human Genetics

Myriad Genetics announced a MyRisk® Hereditary Cancer Test with RiskScore® study was named as one of the top 10 significant advances in genomic medicine.
December 10, 2024 08:00 ET | Source: Myriad Genetics, Inc.

Myriad Genetics’ Portfolio Elevated by Updated NCCN Prostate Cancer Guidelines

Myriad Genetics’ full suite of urologic oncology products is elevated by updated NCCN prostate cancer guidelines.
December 09, 2024 16:05 ET | Source: Myriad Genetics, Inc.

Myriad Genetics to Present New Data at San Antonio Breast Cancer Symposium

Myriad Genetics, Inc. announced it will present new data at the 2024 San Antonio Breast Cancer Symposium.
July 17, 2024 08:00 ET | Source: Myriad Genetics, Inc.

What We Don’t Know Can Hurt: New Cancer Risk Survey from Myriad Genetics Reveals Serious Knowledge Gaps About Breast Density and Cancer Risk

SALT LAKE CITY, July 17, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced results from its nationwide Cancer Risk...